Quantics provides best practice bioassay statistics, is a key opinion leader in this developing field and is involved with guideline development and discussions with the US Pharmacopeia.

QUANTICS provides optimization of pre-clinical programs, ensuring that the maximum available information is extracted from the experimental data.

Quantics can provide all the standard PK analysis and reporting required for drug development.

We can provide all the design and data services for PI -PIII clinical trials to GCP standards.

Traditional meta-analysis or cutting edge indirect treatment comparisons. We have the skills and experience.

Quantics also works in the NHS health sector, ecotoxicology and food science where our experience of analysis of highly variable data is particularly valuable.